No takes yet. Share an insight, caveat, or question.
Randomized trial evaluates AI's cost-effectiveness and diagnostic performance in rural diabetic retinopathy screening, indicating its potential to reduce blindness.
Singh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: